Laboratorios Richmond S.A.C.I.F. (BCBA:RICH)
1,695.00
-20.00 (-1.17%)
Apr 10, 2026, 4:58 PM BRT
Laboratorios Richmond S.A.C.I.F. Company Description
Laboratorios Richmond S.A.C.I.F., together with its subsidiaries, develops, manufactures, and sells pharmaceutical products in Latin America, Africa, Asia, and the Middle East.
It offers antiretroviral drugs for the treatment of human immunodeficiency virus; oncology and oncohematology drugs; cardiometabolism drugs, including antihypertensive, hypocholesterolemic, platelet antiaggregants, and hypoglycemic drugs; and neurological and psychiatric drugs, such as analgesics, antipsychotics, antidepressants, anti-dementia, antiepileptics, and hypnotic drugs, as well as drugs for the treatment of multiple sclerosis.
The company was incorporated in 1959 and is headquartered in Buenos Aires, Argentina.
Laboratorios Richmond S.A.C.I.F.
| Country | Argentina |
| Founded | 1959 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 620 |
| CEO | Juan Manuel Artola |
Contact Details
Address: Bouchard 680 Buenos Aires Argentina | |
| Phone | 54 11 5555 1600 |
| Website | richmondlab.com |
Stock Details
| Ticker Symbol | RICH |
| Exchange | Buenos Aires Stock Exchange |
| Share Class | Class B Shares |
| Fiscal Year | January - December |
| Reporting Currency | ARS |
| ISIN Number | ARLRIC300027 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Juan Manuel Artola | Chief Executive Officer and Director |
| Ruben Jorge Alvarez | Chief Financial Officer |
| Norberto Pablo Garcia Santallin | Executive Vice President and Director |
| R.A. Patricio Carballes | Vice President of Legal Affairs and Director |